Clinical trial

Assessment of Digital Consultations on Clinical Impact and Efficiency Using a RCT (ADMINISTER) Trial

Name
123456567
Description
Healthcare workers have a high workload as compared to other sectors and this burden is projected to increase due to an aging society. It is and will in the future be challenging to deliver optimal HF care because of personnel shortages, the high costs of healthcare, intensive GDMT uptitration schedules, and an epidemic rise in HF patients.This study aims to evaluate the impact of digital consultations (DC) on efficiency and clinical impact in heart failure (HF) patients. A randomized controlled trial on multifaceted digital consults including 1) digital data sharing (e.g. exchange of pharmacotherapy use, home measured vital signs, etc), 2) patient education via an eLearning, and 3) digital guideline recommendations to treating physicians. Included patients will be randomly (1:1) assigned to the intervention group or standard care. The ADMINISTER trial is expected to offer the first robust randomized controlled multicenter data of GDMT prescription rates, time till full GDMT optimization, time spent on healthcare, patient satisfaction and quality of life of digital consults in GDMT optimization.
Trial arms
Trial start
2022-09-01
Estimated PCD
2024-06-06
Trial end
2024-06-06
Status
Active (not recruiting)
Treatment
Digital consult
Consultations will be prepared digitally using the Mychart patient portal, an elearning and questionnaires. The consultation takes place via Teams.
Arms:
Patients receiving digital consultations
Size
150
Primary endpoint
Prescription rate of ACE/ARNI according to the guidelines
12 weeks after baseline
Prescription rate of betablockers according to the guidelines
12 weeks after baseline
Prescription rate of MRA according to the guidelines
12 weeks after baseline
Prescription rate of SGLT2i according to the guidelines
12 weeks after baseline
Prescription rate of periodic screening of iron insufficiency
12 weeks after baseline
Eligibility criteria
Inclusion Criteria: * HFrEF Exclusion Criteria: * Patients not in possession of any attributes to perform the consults digitally
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Randomized controlled trial', 'primaryPurpose': 'SUPPORTIVE_CARE', 'maskingInfo': {'masking': 'NONE', 'maskingDescription': 'Masking the clinicians of the control group assignment is done to optimally capture local practice. Masking of the intervention group is not feasable as patients and healthcare workers will know whether they are receiving normal care or digital care. Outcome measures are determined beforehand.'}}, 'enrollmentInfo': {'count': 150, 'type': 'ACTUAL'}}
Updated at
2024-03-07

1 organization

1 product

1 indication